Sagittarius Life Science Corp (TPEX:3205)

Sagittarius Life Science Statistics

Total Valuation

TPEX:3205 has a market cap or net worth of TWD 3.65 billion. The enterprise value is 3.51 billion.

Market Cap	3.65B
Enterprise Value	3.51B

Important Dates

The next estimated earnings date is Thursday, August 13, 2026.

Earnings Date	Aug 13, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:3205 has 67.55 million shares outstanding. The number of shares has increased by 91.49% in one year.

Current Share Class	67.55M
Shares Outstanding	67.55M
Shares Change (YoY)	+91.49%
Shares Change (QoQ)	-1.63%
Owned by Insiders (%)	38.79%
Owned by Institutions (%)	n/a
Float	20.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.30
PB Ratio	3.60
P/TBV Ratio	3.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-114.83
EV / Sales	8.95
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-36.45

Financial Position

The company has a current ratio of 11.77, with a Debt / Equity ratio of 0.02.

Current Ratio	11.77
Quick Ratio	3.18
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.24
Interest Coverage	-843.69

Financial Efficiency

Return on equity (ROE) is -4.34% and return on invested capital (ROIC) is -7.42%.

Return on Equity (ROE)	-4.34%
Return on Assets (ROA)	-3.26%
Return on Invested Capital (ROIC)	-7.42%
Return on Capital Employed (ROCE)	-4.07%
Weighted Average Cost of Capital (WACC)	6.05%
Revenue Per Employee	3.50M
Profits Per Employee	-272,848
Employee Count	112
Asset Turnover	0.49
Inventory Turnover	11.02

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.96% in the last 52 weeks. The beta is 0.33, so TPEX:3205's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	+27.96%
50-Day Moving Average	56.32
200-Day Moving Average	51.84
Relative Strength Index (RSI)	44.75
Average Volume (20 Days)	178,654

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:3205 had revenue of TWD 392.26 million and -30.56 million in losses. Loss per share was -0.49.

Revenue	392.26M
Gross Profit	53.32M
Operating Income	-41.34M
Pretax Income	-31.07M
Net Income	-30.56M
EBITDA	-37.76M
EBIT	-41.34M
Loss Per Share	-0.49

Balance Sheet

The company has 164.03 million in cash and 23.36 million in debt, with a net cash position of 140.67 million or 2.08 per share.

Cash & Cash Equivalents	164.03M
Total Debt	23.36M
Net Cash	140.67M
Net Cash Per Share	2.08
Equity (Book Value)	1.01B
Book Value Per Share	15.24
Working Capital	783.02M

Cash Flow

In the last 12 months, operating cash flow was -96.18 million and capital expenditures -89,000, giving a free cash flow of -96.27 million.

Operating Cash Flow	-96.18M
Capital Expenditures	-89,000
Depreciation & Amortization	3.58M
Net Borrowing	17.85M
Free Cash Flow	-96.27M
FCF Per Share	-1.43

Margins

Gross margin is 13.59%, with operating and profit margins of -10.54% and -7.79%.

Gross Margin	13.59%
Operating Margin	-10.54%
Pretax Margin	-7.92%
Profit Margin	-7.79%
EBITDA Margin	-9.63%
EBIT Margin	-10.54%
FCF Margin	n/a

Dividends & Yields

TPEX:3205 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-91.49%
Shareholder Yield	-91.49%
Earnings Yield	-0.84%
FCF Yield	-2.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 17, 2016. It was a forward split with a ratio of 1.048659339.

Last Split Date	Aug 17, 2016
Split Type	Forward
Split Ratio	1.048659339

Scores

Altman Z-Score	n/a
Piotroski F-Score	1